Skip to main content
Premium Trial:

Request an Annual Quote

Alnylam and Isis License microRNA Patent Applications from Max Planck Society

NEW YORK, Oct. 19 (GenomeWeb News) - Alnylam Pharmaceuticals and Isis Pharmaceuticals have co-exclusively licensed RNAi patent applications from the Max Planck Society, the companies said today.


Under the agreement, Max Planck Society, of Germany, grants Alnylam of  Cambridge, Mass., and Isis ofCarlsbad, Calif., rights to all therapeutic uses of more than 100 naturally occurring mammalian microRNAs.


These microRNAs, discovered by Thomas Tuschl, a co-founder of Alnylam, could potentially become drug targets or therapeutic products, according to the companies.

The Scan

Pig Organ Transplants Considered

The Wall Street Journal reports that the US Food and Drug Administration may soon allow clinical trials that involve transplanting pig organs into humans.

'Poo-Bank' Proposal

Harvard Medical School researchers suggest people should bank stool samples when they are young to transplant when they later develop age-related diseases.

Spurred to Develop Again

New Scientist reports that researchers may have uncovered why about 60 percent of in vitro fertilization embryos stop developing.

Science Papers Examine Breast Milk Cell Populations, Cerebral Cortex Cellular Diversity, Micronesia Population History

In Science this week: unique cell populations found within breast milk, 100 transcriptionally distinct cell populations uncovered in the cerebral cortex, and more.